Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $302,379 - $348,995
4,491 New
4,491 $345,000
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $6,167 - $18,422
168 Added 0.26%
64,949 $2.52 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $1.99 Million - $2.66 Million
56,416 Added 674.43%
64,781 $2.41 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $342,128 - $377,261
8,365 New
8,365 $370,000
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $171,315 - $201,915
-4,500 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $387,561 - $431,272
-9,400 Reduced 67.63%
4,500 $195,000
Q2 2021

Aug 13, 2021

SELL
$38.58 - $44.24 $100,346 - $115,068
-2,601 Reduced 15.76%
13,900 $594,000
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $576,946 - $648,921
-16,358 Reduced 49.78%
16,501 $638,000
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $8.22 Million - $10.4 Million
-248,055 Reduced 88.3%
32,859 $1.18 Million
Q3 2020

Nov 13, 2020

BUY
$34.44 - $42.23 $8.64 Million - $10.6 Million
250,914 Added 836.38%
280,914 $10.7 Million
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $3.96 Million - $5.13 Million
-131,100 Reduced 81.38%
30,000 $1.05 Million
Q1 2020

May 14, 2020

SELL
$25.83 - $45.71 $20.9 Million - $37 Million
-809,919 Reduced 83.41%
161,100 $5.26 Million
Q2 2019

Aug 13, 2019

BUY
$34.91 - $42.98 $33.9 Million - $41.7 Million
971,019 New
971,019 $41.7 Million
Q1 2019

May 08, 2019

SELL
$32.91 - $40.75 $1.29 Million - $1.59 Million
-39,129 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $1.05 Million - $1.29 Million
33,129 Added 552.15%
39,129 $1.38 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $157,560 - $175,020
6,000
6,000 $175,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.